Overcoming Drug Resistance in Gynecologic Cancers provides up-to-date information related to important gynecologic cancers focusing on the mechanisms of drug resistance, genetics, signaling, immunology, health disparities, nanotechnology, and economic considerations/financial impact. It covers not only drug resistance but important means to reverse resistance both in the laboratory and clinic. The book discusses topics such as lifestyle, nutrition and risk of gynecologic cancers; the financial impact of drug resistance; chemosensitizing agents and targeted therapies in cervical, endometrial and ovarian cancer; immunotherapy to overcome drug resistance; and genetic polymorphisms in gynecologic cancers. Additionally, it discusses ethnic and racial health disparity perspectives and future developments in chemosensitizing activities to reverse drug resistance in gynecologic cancers. It is a valuable resource for cancer researchers, oncologists, clinicians and other biomedical field members who are interested in new approaches to improve chemotherapy outcome in patients with gynecologic cancers. Provides the content in comprehensive manner to provide details needed for readers to understand and follow the informationEncompasses schematics, diagrams and flow charts in all chapters to help the readers to easily follow critical information presentedPresents tables and figures especially developed to summarize the information with appropriate statistical rigor and to show details of clinical specimens such as pathological, radiological characteristics, and/or laboratory biomarkers INDICE: 1. Introduction to gynecologic cancers: An emphasis on pathogenesis, incidence sand diagnosis2. Lifestyle, nutrition, and risk of gynecologic cancers3. Handy impact of drug resistance in gynecologic cancers4. Handling impact of drug resistance in gynecologic cancers: financial and management perspective5. Drug resistance in gynecologic cancers: Findings and underlying mechanisms6. Tentative Title: Overcoming drug resistance in cervical cancer: chemosensitizing agents; targeted therapies 7. Tentative Title: Overcoming drug resistance in ovarian cancer: chemosensitizing agents; targeted therapies8. Overcoming Chemotherapy Resistance in Endometrial Cancer9. Current treatment modalities in gynecologic cancers: Elucidating response rates10. Resistance to chemotherapy among ethnic and racial groups. Health disparities perspectives in gynecologic cancers11. Immunotherapy to overcome drug resistance in gynecologic cancers12. Genetic polymorphisms in Gynecologic Cancers13. Future perspectives and new directions in chemosensitzing activities to reverse drug resistance in gynecologic cancers
- ISBN: 978-0-12-824299-5
- Editorial: Academic Press
- Encuadernacion: Cartoné
- Páginas: 300
- Fecha Publicación: 01/05/2021
- Nº Volúmenes: 1
- Idioma: Inglés